https://biotechmorning.com/news/moonlake-sonelokimab-izar-1-trial-results-wall-street Biotech Morning en 2026-08-17T14:17:08.457Z MoonLake's Drug Aced Its Biggest Test. Wall Street Shrugged. https://biotechmorning.com/news/oncosil-fda-approval-bile-duct-cancer-device Biotech Morning en 2026-08-17T14:16:20.663Z A Tiny Radioactive Implant Just Crashed the Bile Duct Cancer Party https://biotechmorning.com/news/eyepoint-duravyu-lugano-phase-3-wet-amd-mixed-results Biotech Morning en 2026-08-17T14:15:38.434Z EyePoint's Eye Drug Worked — Except When It Didn't https://biotechmorning.com/news/biotech-vc-funding-gap-widens-h1-2026 Biotech Morning en 2026-08-17T14:14:46.884Z $9.1 Billion Poured Into Biotech. Most Startups Didn't See a Dime. https://biotechmorning.com/news/sandoz-henlius-biosimilar-deal-china Biotech Morning en 2026-08-17T14:14:03.033Z Sandoz Is Buying Its Biosimilar Future From China https://biotechmorning.com/news/lilly-370m-ion-channel-omniab-deal Biotech Morning en 2026-08-17T14:13:14.925Z Lilly's $370M Bet on the Drug Targets Nobody Wanted https://biotechmorning.com/news/astrazeneca-bispecific-antibody-trial-flop Biotech Morning en 2026-08-17T14:12:26.062Z AstraZeneca's Big Bet on a Two-for-One Cancer Drug Just Flopped https://biotechmorning.com/news/ribox-circular-rna-in-vivo-car-therapy-fda-clearance Biotech Morning en 2026-08-17T14:11:37.768Z The First Drug That Builds Cancer-Killing Cells Inside Your Body https://biotechmorning.com/news/charles-river-labs-bellwether-biotech-recovery Biotech Morning en 2026-08-16T14:16:41.421Z The Canary in Biotech's Coal Mine Just Started Singing https://biotechmorning.com/news/biomarin-270-million-phase-3-failure Biotech Morning en 2026-08-16T14:15:56.795Z BioMarin Just Lit $270 Million on Fire https://biotechmorning.com/news/capricor-stock-surge-after-fda-adcom-rejection-duchenne Biotech Morning en 2026-08-16T14:15:16.510Z The Biotech Stock That Crashed, Then Pulled a Houdini https://biotechmorning.com/news/fda-commissioner-kalvista-drug-rejection Biotech Morning en 2026-08-16T14:14:27.738Z When the FDA Commissioner Tries to Kill a Drug Himself https://biotechmorning.com/news/bms-15-billion-hengrui-china-deal-2 Biotech Morning en 2026-08-16T14:13:46.528Z BMS Just Bet $15 Billion on China's Hottest Drug Factory https://biotechmorning.com/news/tavneos-eu-withdrawal-gcp-violations Biotech Morning en 2026-08-16T14:13:00.012Z The Drug That Got Pulled Not for Being Dangerous, but for Lying https://biotechmorning.com/news/cytokinetics-sues-bristol-myers-squibb-patent-dispute Biotech Morning en 2026-08-16T14:12:18.040Z Cytokinetics Just Sued Bristol Myers Over a Drug It Helped Create https://biotechmorning.com/news/cancer-drug-worked-still-rejected-itm-fda Biotech Morning en 2026-08-16T14:11:33.918Z The Cancer Drug That Worked But Still Got Rejected